News

Arabian Post on MSN56m
Singapore Welcomes Wegovy® as a New Prescription Weight‑Loss Option
A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a chronic disease. The product, from Novo Nordisk, is licensed for adults and those ...
Tyla18h
Potentially fatal effect of weight loss drugs prompts new investigation
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Zacks Investment Research on MSN2d
Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?
Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
CVS Caremark drops coverage of popular weight loss drug
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Novo Nordisk submits new Wegovy dose for EU approval
Novo Nordisk submits a higher 7.2 mg dose of Wegovy for EMA approval, backed by trials showing 21% weight loss in obesity and ...
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...